Vertex Pharmaceuticals (VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ ...

Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...

Reports Q4 revenue $2.91B, consensus $2.78B. “2024 marked a year of tremendous growth for Vertex and we anticipate 2025 will be another ...

David Tepper’s Appaloosa LP boosted its stakes in Chinese stocks during the fourth quarter and now counts Alibaba Group Holding as its largest position, according to a securities filing. The ...

U.S. stock futures traded lower Monday night, as investors looked toward key inflation reports due later in the week. Dow Jones Industrial Average futures slipped 67 points, or 0.2%. Futures tied to ...

Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...

U.S. stock futures rose on Monday after Friday’s sharp fall as investors digested the tariff updates and earnings reports.

Shares of Nucor, U.S. Steel, and Steel Dynamics rise after President Donald Trump says he will impose 25% levies on all steel ...

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: ...

U.S. stock index futures edged higher on Sunday evening as investors engaged in dip-buying after steep losses on Friday. The ...